[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335697-105":59,"doc-detail-335697-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-anticancer-activity-of-cannabinol-cbn-and-cannabigerol-cbg-on-acute-myeloid-leukemia-cells","The Anticancer Activity of Cannabinol (CBN) and Cannabigerol (CBG) on Acute Myeloid Leukemia Cells","","Several cannabis plant-derived compounds, especially cannabinoids, show therapeutic potential across diverse diseases, including anticancer activity driven by cannabinoid interactions with the endocannabinoid system (ECS). However, the specific molecular mechanisms and effects on leukemia remain insufficiently clarified. This study evaluates the antileukemic effects of cannabinol (CBN) and cannabigerol (CBG) on acute monocytic THP-1 leukemia cells using viability, morphology, cell-cycle, MTT, flow cytometry, and Western blotting for p53 expression. Both compounds suppressed proliferation, triggered apoptosis, and caused dose- and time-dependent cell-cycle arrest. Results indicate a correlation between p53 upregulation and doses above 50 µM, suggesting involvement of p53-associated signaling pathways, with the need for further mechanistic research.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-anticancer-activity-of-cannabinol-cbn-and-cannabigerol-cbg-on-acute-myeloid-leukemia-cells/335697/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-anticancer-activity-of-cannabinol-cbn-and-cannabigerol-cbg-on-acute-myeloid-leukemia-cells/335697.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of evaluating CBN and CBG in acute myeloid leukemia cells?","Question",{"text":112,"@type":113},"To determine whether cannabinol (CBN) and cannabigerol (CBG) exhibit antileukemic effects on acute monocytic leukemia cells and to characterize their cytotoxic, antiproliferative, and apoptotic outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were THP-1 cell effects of CBN and CBG assessed in the study?",{"text":117,"@type":113},"THP-1 viability, morphology, and cell-cycle changes were measured, alongside MTT assay for dosage effects and flow cytometry to evaluate treatment-dependent responses.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does p53 play according to the study findings?",{"text":121,"@type":113},"Western blotting showed p53 expression changes, with the study suggesting a direct correlation between p53 levels and CBG or CBN doses exceeding 50 µM, implying activation of p53-associated signaling pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335697,1790177122,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nThe Anticancer Activity of Cannabinol (CBN) and Cannabigerol (CBG) on Acute Myeloid Leukemia Cells  \nAhmad Kadriya 1,2, Sarah Forbes-Robertson 3 and Mizied Falah 1,2, *  \nCitation: Kadriya, A.; ForbesRobertson, S.; Falah, M. The Anticancer Activity of Cannabinol (CBN) and Cannabigerol (CBG) on Acute Myeloid Leukemia Cells. Molecules 2024, 29, 5970. [https://](https://)[ ](https://)[doi.org/10.3390/molecules29245970](doi.org/10.3390/molecules29245970)  \n1 Medical Research Institute, The Holy Family Hospital Nazareth, Nazareth 16100, Israel; [ahmadkadriya@gmail.com](ahmadkadriya@gmail.com)  \n2 Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel  \n3 Health & Life Sciences Department, Coventry University, Coventry CV1 5FB, UK; [ac2690@coventry.ac.uk](ac2690@coventry.ac.uk)  \n* [Correspondence: mizied.falah@gmail.com](Correspondence: mizied.falah@gmail.com); Tel.: +972-74-723-1736  \nAbstract: Several cannabis plant-derived compounds, especially cannabinoids, exhibit therapeutic potential in numerous diseases and conditions. In particular, THC and CBD impart palliative, antiemetic, as well as anticancer effects. The antitumor effects include inhibition of cancerous cell growth and metastasis and induction of cell death, all mediated by cannabinoid interaction with the endocannabinoid system (ECS). However, the exact molecular mechanisms are still poorly understood. In addition, their effects on leukemia have scarcely been investigated. The current work aimed to assess the antileukemic effects of CBN and CBG on an acute monocytic leukemia cell line, the THP-1 . THP-1 cell viability, morphology and cell cycle analyses were performed to determine potential cytotoxic, antiproliferative, and apoptotic effects of CBN and CBG. Western blotting was carried out to measure the expression of the proapoptotic p53 . Both CBN and CBG inhibited cell growth and induced THP-1 cell apoptosis and cell cycle arrest in a dose-and time-dependent manner. CBN and CBG illustrated different dosage effects on THP-1 cells in the MTT assay (CBN > 40 µM, CBG > 1 µM) and flow cytometry (CBN > 5 µM, CBG > 40 µM), highlighting the cannabinoids’antileukemic activity. Our study hints at a direct correlation between p53 expression and CBG or CBN doses exceeding 50 µM, suggesting potential activation of p53-associated signaling pathways underlying these effects. Taken together, CBG and CBN exhibited suppressive, cell death-inducing effects on leukemia cells. However, further in-depth research will be needed to explore the molecular mechanisms driving the anticancer effects of CBN and CBG in the leukemia setting.  \nKeywords: leukemia cells; anticancer activity; cannabinoids; cannabinol (CBN); cannabigerol (CBG); enocannabinoid system (ECS)  \n1. Introduction  \nAcademic Editor: Ricardo Calhelha  \nReceived: 5 November 2024  \nRevised: 8 December 2024  \nAccepted: 16 December 2024  \nPublished: 18 December 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nAcute myeloid leukemia (AML) is a deadly disease generally occurring in later adulthood (17 per 100,000 persons above the age of 65 years) but also diagnosed among youth (1.8 per 100,000 persons below the age of 15 years) [1,2] . Up to date analysis shows a growing global burden of AML, particularly in higher Socio-Demographic Index regions, highlighting its impact across all age groups [3] . AML is considered fatal if left untreated, and the median survival is estimated to be between 11 and 20 weeks after diagnosis [1,4] . As defined, AML consists of eight subtypes (from M0–M7) based on cell morphological and cytochemical features. Its pathogenesis compromises the abnormal proliferati","cbCairiM88U7m6PR","https://ap.wps.com/l/cbCairiM88U7m6PR","pdf",2452068,18,"English","# Introduction\n# Materials and Methods\n## Cell Viability and Morphology\n## Cell Cycle and Apoptosis Assays\n## Western Blot Analysis\n# Results\n# Discussion\n# Conclusions","[{\"question\":\"What is the main purpose of evaluating CBN and CBG in acute myeloid leukemia cells?\",\"answer\":\"To determine whether cannabinol (CBN) and cannabigerol (CBG) exhibit antileukemic effects on acute monocytic leukemia cells and to characterize their cytotoxic, antiproliferative, and apoptotic outcomes.\"},{\"question\":\"How were THP-1 cell effects of CBN and CBG assessed in the study?\",\"answer\":\"THP-1 viability, morphology, and cell-cycle changes were measured, alongside MTT assay for dosage effects and flow cytometry to evaluate treatment-dependent responses.\"},{\"question\":\"What role does p53 play according to the study findings?\",\"answer\":\"Western blotting showed p53 expression changes, with the study suggesting a direct correlation between p53 levels and CBG or CBN doses exceeding 50 µM, implying activation of p53-associated signaling pathways.\"}]","The Anticancer Activity of Cannabinol (CBN) and Cannabigerol (CBG) on Acute Myeloid Leukemia Cells | PDF",1790011974,45]